I certainly hope the latest new employee with high-level access to Alcor's operation works out this time.
Yet another "Meet the Suspect Newcomer" article
#1
Posted 01 December 2005 - 11:37 PM
I certainly hope the latest new employee with high-level access to Alcor's operation works out this time.
#2
Posted 06 December 2005 - 07:02 AM
Good luck and best success to Dr. Sheleg!
========================================================================
From the Alcor website
Sergey V. Sheleg, M.D., Ph.D., ext. 120
Chief Research Scientist
sergey@alcor.org
Sergey joined Alcor in 2005. His primary responsibility is to develop the new methods for monitoring circulation of cryoprotectants and blood substitutes (oxygen-carrying volume expanders) in the brain before and during cryonics procedures. He is also working on the problem of designing new methods for preventing severe hypoxic brain damage after cardiac arrest before starting cryonics procedures.
Prior to his joining Alcor, Dr. Sheleg held a Research Associate position at N.N. Alexandrov Research Institute of Oncology and Medical Radiology (Lesnoy, Belarus). Dr. Sheleg worked on the problem of designing new methods of local chemotherapy for malignant brain tumors. At the same time, Dr. Sheleg studied the problem of blood circulation in the brain after warm cardiac arrest.
In 2002, Dr. Sheleg became a postdoctoral fellow at the Center for Biologics Evaluation and Research of the U.S. Food and Drug Administration in the field of molecular cell biology. From 2004 to 2005, Dr. Sheleg held a Visiting Fellow position at National Institutes of Health (National Institute of Allergy and Infectious Diseases) in the field of molecular oncology/cell biology.
Dr. Sheleg received his M.D. from the Belarus State Medical University in 1994 and his Ph.D. in Oncology from N.N. Alexandrov Research Institute of Oncology and Medical Radiology (Lesnoy, Belarus) in 2002. He has more than 20 published papers in the fields of neuro-ocology, neuro-infectious diseases, brain anoxia, and molecular cell biology:
Sheleg S.V., Zhavrid E.A., Khodina T.V., Kochubeev G.A., Istomin Y.P., Chalov V.N., Zhuravkin I.N.: Photodynamic therapy with chlorin e(6) for skin metastases of melanoma. Photodermatol. Photoimmunol. Photomed. 20: 21–6 2004
Sheleg S.V., Korotkevich E.A., Zhavrid E.A., Muravskaya G.V., Smeyanovich A.F., Shanko Y.G., Yurkshtovich T.L., Bychkovsky P.B., Belyaev S.A.: Local chemotherapy with cisplatin-depot for glioblastoma multiforme. J. Neurooncol. 60: 53–9, 2002
Sheleg, S.V., Nedzved, M.K., Nedzved, A.M., Kulichkovskaya, I.V.: Contamination of glioblastoma multiforme with type 1 herpes simplex virus. J. Neurosurg. 95: 721, 2001
#3
Posted 07 December 2005 - 12:56 AM
He has more than 20 published papers in the fields of neuro-ocology, neuro-infectious diseases, brain anoxia, and molecular cell biology:
Sheleg S.V., Zhavrid E.A., Khodina T.V., Kochubeev G.A., Istomin Y.P., Chalov V.N., Zhuravkin I.N.: Photodynamic therapy with chlorin e(6) for skin metastases of melanoma. Photodermatol. Photoimmunol. Photomed. 20: 21–6 2004
Sheleg S.V., Korotkevich E.A., Zhavrid E.A., Muravskaya G.V., Smeyanovich A.F., Shanko Y.G., Yurkshtovich T.L., Bychkovsky P.B., Belyaev S.A.: Local chemotherapy with cisplatin-depot for glioblastoma multiforme. J. Neurooncol. 60: 53–9, 2002
Sheleg, S.V., Nedzved, M.K., Nedzved, A.M., Kulichkovskaya, I.V.: Contamination of glioblastoma multiforme with type 1 herpes simplex virus. J. Neurosurg. 95: 721, 2001
Why doesn't Alcor list his papers on "brain anoxia" instead? This is more relevant to the work he is doing at Alcor now.
#4
Posted 14 December 2005 - 11:10 PM
#5
Posted 08 December 2006 - 01:03 AM
http://www.alcornews...aves_alcor.html
Dr. Sheleg Leaves Alcor
We regret to announce that Dr. Sergey Sheleg is no longer employed by Alcor. Employment matters must always be kept confidential, so there is not much more we can say.
We wish Dr. Sheleg the best of luck in his future endeavors.
Posted by admin on December 7, 2006 02:46 PM |
#7
Posted 08 December 2006 - 04:44 AM
Well there is the IBPT story.
Brian Wowk posted on Dec. 1 over at Alcor United:
That company and that website were apparently an initiative of Dr. Sheleg taken without knowledge of Alcor's board. We learned about it from Yuri's Pichugin's CryoNet post at the same time as everyone else. The nature of the involvement of other staff members is still being investigated. They apparently did not know or approve of the website. It's my understanding that the website has been taken down, and involved parties have been instructed that running off and creating websites that promote personal ideas related to one's employment is not how things are supposed to be done.
So either Dr. Sheleg quit, or else Alcor fired him, for setting up a website and apparently a company to promote his own cryobiological ideas? Seems like he would have had to do more than that to justify termination, like helping himself to more equipment, money or intellectual property than he had entitlement to under his conditions of employment.
#8
Posted 08 December 2006 - 07:01 AM
PS. advancedatheist why don't you post at Alcor United any more?
Edited by Neurosail, 08 December 2006 - 07:47 AM.
#9
Posted 09 December 2006 - 06:57 AM
--Jon
Only good guys finnish first.
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users